Recurrent Kidney Stones: A Naturopathic Approach

Alternative and Complementary Therapies

Volumn 4, Issue 1, 1998, Pages 60-67

  Heron, Silena ^a   Yarnell, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50049129167     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/act.1998.4.60     Document Type: Article

References (46)

1. Unwin, R. Unravelling of the molecular mechanisms of kidney stones: Introduction. Lancet 348: 1561–1562, 1996.
2. Robertson, W., Peacock, M. The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria. Nephron 26: 105–110, 1980.
3. Borsatti, A. Calcium oxalate nephrolithiasis: Defect oxalate transport. Kidney Intl 39: 1283–1298, 1991.
4. Brinkley, L., McGuire, J., et al. Bioavailability of oxalate in foods. Urology 17: 534–538, 1981.
5. Laminski, N. A., Meyers, A. M., et al. Hyperoxaluria in patients with recurrent calcium oxalate calculi: Dietary and other risk factors. Br J Urol 68: 454–458, 1991.
6. Massey, L. K., Roman-Smith, H., Sutton, R. A. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc 93: 901–906, 1993.
7. Curhan, G. C., Willet, W. C., Speizer, F. E., et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126: 497–504, 1997.
8. Burtis, W. J., Gay, L., Insogna, K. L., et al. Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr 60: 424–429, 1994.
9. Muldowney, F. P., Freaney, R., Moloney, M. F. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Intl 22: 292–296, 1982.
10. Lemann, J., Jr., Piering, W. F., Lennon, E. J. Possible role of carbohydrate-induced calciuria in calcium oxalate kidney-stone formation. N Engl J Med 280: 232–237, 1969.
11. Hughes, J., Norman, R. W. Diet and calcium stones. Can Med Assoc J. 146: 137–143, 1992 [review].
12. Seltzer, M. A., Low, R. K., McDonald, M., et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 156: 907–909, 1996.
13. Akinci, M., Esen, T., Koçak, T., et al. Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations. Eur Urol 19: 240–243, 1991.
14. Murthy, M., Farooqui, S., et al. Effect of pyridoxine supplementation on recurrent stone formers. Intl J Clin Pharm Ther Tox 20: 43–47, 1982.
15. Prien, E., Gershoff, S. Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi. J Urol 112: 509–512, 1974.
16. Piesse, J. W. Nutritional factors in calcium containing kidney stones with particular emphasis on vitamin C. Intl Clin Nutr Rev 5(3): 110–129, 1985 [review].
17. Johansson, G., Backman, U., et al. Magnesium metabolism in renal stone formers: Effects of therapy with magnesium hydroxide. Scand J Urol Nephrol 53: 125–130, 1980.
18. Braeckman, J. The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study. Curr Ther Res 55: 776–785, 1994.
19. Amin, A. H., Subbaiah, T. V., Abbasi, K. M. Berberine sulfate: Antimicrobial activity, bioassay and mode of action. Can J Microbiol 15: 1067–1076, 1969.
20. Kupin, W., Preminger, G. M., Segura, J., Smith, A. A treatment plan for urinary stones. Patient Care (May 30): 22–38, 1995 [review].
21. Robinson, T. The biochemical pharmacology of plant alkaloids. Herbs Spices Med Plants 1: 135–165, 1986 [review].
22. Bablumian, I. U. A., Petrosian, B. G. Extract from the roots of Rubia tinctorum in the treatment of ureteral calculi. Zh Eksp Klin Med 17(6): 87–91, 1977 [in Russian].
23. Gilani, A. H., Janbaz, K. H., Zaman, M., et al. Possible presence of calcium channel blocker(s) in Rubia cordifolia: An indigenous medicinal plant. JPMA J Pak Med Assoc 44(4): 82–85, 1994.
24. Ino, N., Tanaka, T., Okumura, A., et al. Acute and subacute toxicity tests of madder root, natural colorant extracted from madder (Rubia tinctorum), in (C57BL/6 X C3H)F1 mice. Toxicol Ind Health 11(4):449–458, 1995.
25. Kennedy, M. C. S., Stock, J. P. P. The bronchodilator action of khellin. Thorax 7: 43–65, 1952.
26. Conn, J. J., Kisane, R. W., Koons, R. A., Clark, T. E. Treatment of angina pectoris with khellin. Ann Intern Med 36: 1173–1178, 1952.
27. Rauwald, H. W., Brehm, O., Odenthal, K. P. The involvement of a Ca2+-channel blocking mode of action in the pharmacology of Ammi visnage fruits. Planta Med 60: 101–105, 1994.
28. Duarte, J., Perez-Vizcaino, F., Torres, A. I., et al. Vasodilator effects of visnagin in isolated rat vascular smooth muscle. Eur J Pharmacol 286(2): 115–122, 1995.
29. Abdulla, W. A., Kadry, H., Mahran, S. G., et al. Preliminary studies on the anti-schistosomal effect of Ammi majus L. Egypt J Bilharz 4(1): 19–26, 1978.
30. Felter, H. W., Lloyd, J. U. King's American Dispensatory. Portland, OR: Eclectic Medical Publications, reprint of 18th edition, 1898 original, pp. 740–743.
31. Wilhelm, K., Feldmeier, C. Thermometric investigations about the efficacy of beta-escin to reduce postoperative edema. Med Klin 72(4): 128–134, 1977 [in German].
32. Longiave, D., Omini, C., Nicosia, S., Berti, F. The mode of action of escin on isolated veins. Pharmacol Res 10: 145–152, 1978.
33. Weiss, R. F. Herbal Medicine. Beaconsfield, UK: Beaconsfield Publishers, Ltd., 1985.
34. Doan, D. D., Nguyen, N. H., Doan, H. K., et al. Studies on the individual and combined diuretic effects of four Vietnamese traditional herbal remedies (Zea mays, Imperata cylindrica, Plantago major and Orthosiphon stamineus). J Ethnopharm 36: 225–231, 1992.
35. Racz-Kotilla, E., Racz, G., Solomon, A. The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med 26: 212–217, 1974.
36. Grases, F., Melero, G., Costa-Bauza, A., et al. Urolithiasis and phytotherapy. Intl Urol Nephrol 26: 507–511, 1994.
37. Hyde, F. F. The leaf of Taraxacum officinale L. New Herbal Practitioner 1: 82, 1975.
38. Tyler, V. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York: Pharmaceutical Products Press, 1994, pp. 74–75.
39. Leuschner, J. Anti-inflammatory, spasmolytic and diuretic effects of a commercially available Solidago gingantea herb extract. Arzneim Forsch 45: 165–168, 1995.
40. von Wagener, H. H. The pharmacology of venous drugs containing an extract of Solidago. Arzneim Forsch 16: 859–866, 1966 [in German].
41. D'Agostino, M., Dini, A., Pizza, C., et al. Sterols from Equisetum arvense. Boll Soc Ital Biol Sper 60: 2241–2245, 1984.
42. Berges, R. R., Windeler, J., Trampisch, J. H., et al. Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasia. Lancet 345: 1529–1532, 1995.
43. Lemus, I., Garcia, R., Erazo, S., et al. Diuretic activity of an Equisetum bogotense tea (platero herb): Evaluation in healthy volunteers. J Ethnopharmacol 54(1): 55–58, 1996.
44. Perez Gutierrez, R. M., Laguna, G. Y., Walkowski, A. Diuretic activity of Mexican equisetum. J Ethnopharmacol 14: 269–272, 1985.
45. Paslawska, S., Piekos, R. Studies on the optimum conditions of extraction of silicon species from plants with water. IV. Agropyron repens. Planta Med 30: 216–222, 1976.
46. Grases, F., Ramis, M., Costa-Bauza, A., March, J. G. Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis risk in rats. J Ethnopharmacol 45: 211–214, 1995.